Activated Epidermal Growth Factor Receptor in Ovarian Cancer

作者: Laurie G. Hudson , Reema Zeineldin , Melina Silberberg , M. Sharon Stack

DOI: 10.1007/978-0-387-98094-2_10

关键词: Tyrosine kinaseBetacellulinEpidermal growth factor receptorEpidermal growth factorCancer researchGrowth factor receptorErbBGrowth factor receptor inhibitorChemistryReceptor tyrosine kinase

摘要: Growth factor receptors direct numerous cellular functions and behavior including cell proliferation survival, apoptosis, differentiation, migration. The receptor tyrosine kinase (RTK) family of growth includes the epidermal (EGF) subfamily (also known as ErbB or type I RTKs). four proteins: ErbB-1 (EGF receptor), ErbB2, ErbB3, ErbB4. These structurally related, single membrane spanning consist an extracellular ligand-binding domain, a transmembrane juxtamembrane catalytic C-terminal tail containing multiple residues (Fig. 10.1). Ligand binding promotes EGF homoand heterodimerization with members, activation intracellular phosphorylation specific cytoplasmic domain. This leads to assembly signaling complexes stimulation downstream cascades associated increased angiogenesis, metastasis in tumors. Numerous ligands interact family. EGF, transforming factor-a (TGF-a), amphiregulin only bind receptor. heparin-binding EGF-like (HBEGF), betacellulin, epiregulin, epigen both are synthesized membrane-bound precursors then cleaved release mature form ligand. can activate on origin, nearby cells, cells at more distant sites after systemic distribution. In some instances, by precursor (membrane-bound ligand) may occur consequence

参考文章(193)
Veerle L. Van Marck, Marc E. Bracke, Epithelial-Mesenchymal Transitions in Human Cancer Rise and fall of Epithelial Phenotype : concepts of Epithelial-Mesenchymal transition. pp. 135- 159 ,(2005) , 10.1007/0-387-28671-3_9
K. C. Podratz, N. J. Maihle, A. T. Baron, B. A. Barrette, C. H. Boardman, T. A. Christensen, E. M. Cora, J. M. Faupel-Badger, T. Greenwood, S. C. Juneja, J. M. Lafky, H. Lee, J. L. Reiter, EGF/ErbB Receptor Family in Ovarian Cancer Ovarian Cancer. ,vol. 107, pp. 247- 258 ,(2002) , 10.1007/978-1-4757-3587-1_11
Ben Davidson, Iris Goldberg, Walter H. Gotlieb, Juri Kopolovic, Gilad Ben-Baruch, Jahn M. Nesland, Aasmund Berner, Magne Bryne, Reuven Reich, High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma. Clinical & Experimental Metastasis. ,vol. 17, pp. 799- 808 ,(1999) , 10.1023/A:1006723011835
Valérie Arnoux, Christophe Côme, Donna F. Kusewitt, Laurie G. Hudson, Pierre Savagner, Cutaneous Wound Reepithelialization Springer, Boston, MA. pp. 111- 134 ,(2005) , 10.1007/0-387-28671-3_8
Alice S. T. Wong, Nelly Auersperg, Normal Ovarian Surface Epithelium Ovarian Cancer. ,vol. 107, pp. 161- 183 ,(2002) , 10.1007/978-1-4757-3587-1_7
Andrew Berchuck, Robert C Bast, Cinda M. Boyer, Lorri Everitt, George J. Olt, Andrew P. Soisson, The role of peptide growth factors in epithelial ovarian cancer Obstetrics & Gynecology. ,vol. 75, pp. 255- 262 ,(1990)
Marlon R. Schneider, Sabine Werner, Ralf Paus, Eckhard Wolf, Beyond Wavy Hairs The American Journal of Pathology. ,vol. 173, pp. 14- 24 ,(2008) , 10.2353/AJPATH.2008.070942
Oliver M. Fischer, Stefan Hart, Axel Ullrich, Dissecting the epidermal growth factor receptor signal transactivation pathway. Methods of Molecular Biology. ,vol. 327, pp. 85- 97 ,(2006) , 10.1385/1-59745-012-X:85
M Sharon Stack, David A Fishman, Supurna Ghosh, Yi Wu, M Sharon Stack, Ovarian Cancer- Associated Proteinases Ovarian Cancer. ,vol. 107, pp. 331- 351 ,(2002) , 10.1007/978-1-4757-3587-1_16
Elizabeth D. Hay, EMT Concept and Examples from the Vertebrate Embryo Springer, Boston, MA. pp. 1- 11 ,(2005) , 10.1007/0-387-28671-3_1